Abstract | UNLABELLED: METHODS: The accumulation and washout of 99mTc-TF were observed in both cell lines at 37 degrees C. The effect of verapamil on the kinetics was also assessed. RESULTS: 99mTc-TF net accumulation was significantly lower in HL60/DOX (1.35 +/- 0.23%) than in HL60/WT (12.79 +/- 0.47%) at 60 min (P < 0.001). Three minutes after exchanging the incubation solution to the tracer-free medium, only 18.20 +/- 0.34% of 99mTc-TF remained in HL60/DOX, whereas 84.74 +/- 0.65% did in HL60/WT (P < 0.001). In the presence of 10 microM verapamil, 99mTc-TF net accumulation in HL60/DOX was 302% of the control and the washout was significantly delayed. CONCLUSION: 99mTc-TF would be a substrate for MRP and 99mTc-TF may be used as a functional imaging agent of MRP in vivo.
|
Authors | X F Li, S Kinuya, K Yokoyama, S Konishi, Y Y Ma, N Watanabe, N Shuke, H Bunko, T Michigishi, N Tonami |
Journal | Cancer biotherapy & radiopharmaceuticals
(Cancer Biother Radiopharm)
Vol. 16
Issue 1
Pg. 17-23
(Feb 2001)
ISSN: 1084-9785 [Print] United States |
PMID | 11279794
(Publication Type: Comparative Study, Journal Article)
|
Chemical References |
- ATP Binding Cassette Transporter, Subfamily B, Member 1
- Calcium Channel Blockers
- Neoplasm Proteins
- Organophosphorus Compounds
- Organotechnetium Compounds
- Radiopharmaceuticals
- technetium tc-99m tetrofosmin
- Doxorubicin
- Technetium Tc 99m Sestamibi
- Verapamil
|
Topics |
- ATP Binding Cassette Transporter, Subfamily B, Member 1
(genetics, metabolism)
- Biological Transport
(drug effects)
- Calcium Channel Blockers
(pharmacology)
- Doxorubicin
(pharmacology)
- Drug Resistance, Multiple
- Drug Resistance, Neoplasm
- Gene Expression Regulation, Leukemic
- HL-60 Cells
(drug effects, metabolism)
- Humans
- Kinetics
- Neoplasm Proteins
(genetics, metabolism)
- Organophosphorus Compounds
(metabolism)
- Organotechnetium Compounds
(metabolism)
- Radiopharmaceuticals
(metabolism)
- Substrate Specificity
- Technetium Tc 99m Sestamibi
(metabolism)
- Tomography, Emission-Computed
- Verapamil
(pharmacology)
|